{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:14:22Z","timestamp":1791656062967,"version":"4.3.4"},"reference-count":87,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"crossref","award":["YDZJ202401442ZYTS"],"award-info":[{"award-number":["YDZJ202401442ZYTS"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is a neurodegenerative disorder of the central nervous system with a complex pathogenesis. Current conventional medicines are predominantly symptomatic treatments, which fail to reverse neuronal degeneration and often induce severe motor complications following long-term administration. In this context, the advantages of the multi-target holistic regulation provided by traditional Chinese medicine have become increasingly prominent. As the core active ingredients of Panax ginseng, ginsenosides can penetrate the blood\u2013brain barrier and exhibit broad neuroprotective prospects in PD treatment. This article systematically reviews the neuroprotective mechanisms of different configurations of ginsenosides\u2014mainly including protopanaxadiol (PPD) and protopanaxatriol (PPT) saponins\u2014against PD. Studies indicate that PPD-type saponins (e.g., Rb1, Rg3, Rd) excel in directly inhibiting the abnormal aggregation of \u03b1-synuclein (\u03b1-syn), reducing oxidative stress, and preventing neuronal apoptosis. Conversely, PPT-type saponins (e.g., Rg1, Re) demonstrate significant advantages in suppressing microglia-mediated neuroinflammation, improving mitophagy, and regulating lipid metabolism networks. Furthermore, this review highlights a novel intervention strategy utilizing ginsenosides based on antioxidation and iron metabolism regulation. By maintaining the homeostasis of iron transport proteins such as DMT1 (Divalent Metal Transporter 1) and FPN1 (Ferroportin 1), and activating the Nrf2\/xCT\/GPX4 signaling axis, these compounds effectively block the vicious cycle of \u201ciron deposition-oxidative stress-lipid peroxidation (LPO),\u201d thereby inhibiting ferroptosis in dopaminergic neurons. In summary, structurally diverse ginsenosides exhibit distinct characteristics in targeting the core pathological events of PD. The scientific combination of ginsenoside monomers with different mechanisms in the future holds promise for constructing a comprehensive multi-target neuroprotective network, providing a solid theoretical foundation for novel ginsenoside-based combination therapies against PD.<\/jats:p>","DOI":"10.3390\/ijms27104544","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:53:10Z","timestamp":1779191590000},"page":"4544","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Research Progress on the Mechanism of Ginsenosides in the Treatment of Parkinson\u2019s Disease"],"prefix":"10.3390","volume":"27","author":[{"given":"Shanshan","family":"Wang","sequence":"first","affiliation":[{"name":"School of Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun 130117, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun 130117, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haipeng","family":"Tang","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun 130117, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyu","family":"Gong","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun 130117, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejin","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun 130117, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangyu","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun 130117, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"ref_1","first-page":"15","article-title":"Preliminary study on neuroprotective effect of Ginsenoside Rb1 on MPTP-induced Parkinson\u2019s disease model mice","volume":"39","author":"Dai","year":"2023","journal-title":"J. Baotou Med. Coll."},{"key":"ref_2","first-page":"2510","article-title":"Serum vitamin D levels and findings of a study of movement Parkinson\u2019s patients symptoms","volume":"46","author":"Liu","year":"2025","journal-title":"J. Med. Forum"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ncl.2024.12.003","article-title":"Pathogenesis of Parkinson\u2019s Disease","volume":"43","author":"Xiao","year":"2025","journal-title":"Neurol. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"102077","DOI":"10.1016\/j.arr.2023.102077","article-title":"Ferroptosis in Parkinson\u2019s disease: Molecular mechanisms and therapeutic potential","volume":"91","author":"Ding","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000518147","article-title":"Parkinson\u2019s Disease and Gut Microbiota","volume":"77","author":"Hirayama","year":"2021","journal-title":"Ann. Nutr. Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/mds.20324","article-title":"Sydney Multicenter Study of Parkinson\u2019s disease: Non-L-dopa-responsive problems dominate at 15 years","volume":"20","author":"Hely","year":"2005","journal-title":"Mov. Disord."},{"key":"ref_7","first-page":"123","article-title":"Research Progress in the Treatment of Parkinson\u2019s Disease with Traditional Chinese Medicine","volume":"9","author":"Qin","year":"2012","journal-title":"J. Nurs. Pract. Res."},{"key":"ref_8","unstructured":"Zhang, X.R., Zhang, J., Zheng, C.L., Hou, Y.Y., Liu, Z.M., Jia, N., and Cao, Y. (2025). Research Progress on the Mechanisms of Ligusticum chuanxiong and its Compound Prescriptions in the Treatment of Parkinson\u2019s Disease. J. Liaoning Univ. Tradit. Chin. Med., Available online: https:\/\/link.cnki.net\/urlid\/21.1543.R.20251119.1751.022."},{"key":"ref_9","first-page":"1455","article-title":"Exploring the Etiology, Pathogenesis, and Treatment of Parkinson\u2019s Disease Based on the Theory of \u201cConsolidating the Foundation and Cultivating the Source\u201d","volume":"40","author":"Cheng","year":"2025","journal-title":"Acta Chin. Med."},{"key":"ref_10","first-page":"686","article-title":"Progress in treatment of motor complications of Parkinson\u2019s disease with traditional Chinese and western medicine","volume":"19","author":"Pan","year":"2025","journal-title":"Chin. Compend. Typ. Cases"},{"key":"ref_11","first-page":"67","article-title":"Treating 68 cases of tremble of Qixue Kuixu type with the Renshen Yangrong decoction","volume":"5","author":"Wen","year":"2013","journal-title":"Clin. J. Chin. Med."},{"key":"ref_12","first-page":"525","article-title":"Treatment of 28 Cases of Parkinson\u2019s Disease with Integrated Traditional Chinese and Western Medicine","volume":"53","author":"Dong","year":"2018","journal-title":"Zhejiang J. Tradit. Chin. Med."},{"key":"ref_13","first-page":"25","article-title":"Research progress of ginsenosides in the treatment of Alzheimer\u2019s disease","volume":"45","author":"Wang","year":"2025","journal-title":"J. Gannan Med. Univ."},{"key":"ref_14","unstructured":"Zhao, W.X. (2020). Protective Effect of Ginsenosides on Parkinson\u2019s Disease In Vitro and Its Mechanism. [Master\u2019s Thesis, Changchun University of Chinese Medicine]."},{"key":"ref_15","first-page":"12","article-title":"Advances in the molecular mechanisms of \u03b1-synuclein oligomer-mediated neuron-glial cell interactions in Parkinson\u2019s disease neurodegeneration","volume":"22","author":"Zhou","year":"2025","journal-title":"J. Neurol. Neurorehabilit."},{"key":"ref_16","unstructured":"Yang, J.J. (2025). Mechanism of Nicotine Regulation of Cholesterol Metabolism Disorder in 6-OHDA-Induced Parkinson\u2019s Disease Models via \u03b1-nAChR, Zhengzhou Tobacco Research Institute of CNTC."},{"key":"ref_17","first-page":"86","article-title":"Research Progress on the Mechanism of Cistanche Glycosides in the Prevention and Treatment of Parkinson\u2019s Disease","volume":"2","author":"Xu","year":"2025","journal-title":"J. Integr. Traditiomal Chin. West. Med. Chronic Dis."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Sian-Hulsmann, J., and Riederer, P. (2021). The Nigral Coup in Parkinson\u2019s Disease by \u03b1-Synuclein and Its Associated Rebels. Cells, 10.","DOI":"10.3390\/cells10030598"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"134316","DOI":"10.1016\/j.neulet.2019.134316","article-title":"\u03b1-Synuclein pathology in Parkinson\u2019s disease and related \u03b1-synucleinopathies","volume":"709","author":"Henderson","year":"2019","journal-title":"Neurosci. Lett."},{"key":"ref_20","first-page":"120","article-title":"Research Progress on the Multidimensional Pathogenesis of Parkinson\u2019s Disease","volume":"40","author":"Zhang","year":"2026","journal-title":"J. Pract. Tradit. Chin. Intern. Med."},{"key":"ref_21","first-page":"2065","article-title":"Role and mechanism of NRF2 signaling pathway in Parkinson\u2019s disease","volume":"47","author":"Liu","year":"2025","journal-title":"Hebei Med. J."},{"key":"ref_22","first-page":"1817","article-title":"Damage to dopaminergic neurons by oxidative stress in Parkinson\u2019s disease (Review)","volume":"41","author":"Guo","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Afzal, S., Abdul Manap, A.S., Attiq, A., Albokhadaim, I., Kandeel, M., and Alhojaily, S.M. (2023). From imbalance to impairment: The central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1269581"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Pfeifer, G.P. (2024). DNA Damage and Parkinson\u2019s Disease. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25084187"},{"key":"ref_25","first-page":"35","article-title":"Advances in the Molecular Pathogenesis of Parkinson\u2019s Disease","volume":"3","author":"Zhang","year":"2013","journal-title":"Acta Neuropharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Cui, Z., Zhao, X., Amevor, F.K., Du, X., Wang, Y., Li, D., Shu, G., Tian, Y., and Zhao, X. (2022). Therapeutic application of quercetin in aging-related diseases: SIRT1 as a potential mechanism. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.943321"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"101896","DOI":"10.1016\/j.redox.2021.101896","article-title":"Parkinson\u2019s disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies","volume":"41","author":"Ma","year":"2021","journal-title":"Redox Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"105920","DOI":"10.1016\/j.nbd.2022.105920","article-title":"Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson\u2019s disease and Neurodegeneration with Brain Iron Accumulation disorders","volume":"175","author":"Wise","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"An, Y., Li, S., Huang, X., Chen, X., Shan, H., and Zhang, M. (2022). The Role of Copper Homeostasis in Brain Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232213850"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41467-019-13781-3","article-title":"ROCK inhibitors upregulate the neuroprotective Parkin-mediated mitophagy pathway","volume":"11","author":"Moskal","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_31","first-page":"2526","article-title":"Research progress on the regulation of mitochondrial dysfunction by traditional Chinese medicine in the intervention of Parkinson\u2019s disease","volume":"41","author":"Liang","year":"2025","journal-title":"Chin. J. Clin. Pharmacol."},{"key":"ref_32","first-page":"4446","article-title":"Mechanisms underlying mitophagy, ferroptosis, cuproptosis, and disulfidptosis in Parkinson\u2019s disease","volume":"30","author":"Yu","year":"2026","journal-title":"Chin. J. Tissue Eng. Res."},{"key":"ref_33","first-page":"1111","article-title":"Effects of electroacupuncture on cognitive impairment and mitophagy mediated by KIF5A\/Miro1 pathway in Parkinson\u2019s disease mice","volume":"45","author":"Li","year":"2025","journal-title":"Chin. Acupunct. Moxibustion"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1093\/brain\/awac193","article-title":"A Mendelian randomization study investigating the causal role of inflammation on Parkinson\u2019s disease","volume":"145","author":"Bottigliengo","year":"2022","journal-title":"Brain"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/mds.29369","article-title":"Peripheral Inflammation Is Associated with Dopaminergic Degeneration in Parkinson\u2019s Disease","volume":"38","year":"2023","journal-title":"Mov. Disord."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_37","first-page":"275","article-title":"Invasive Vagus Nerve Stimulation Activates Microglia \u03b17nAChR to Reduce Striatal Neuroinflammation in Mouse Model of Parkinson\u2019s Disease and Its Mechanism","volume":"35","author":"Geng","year":"2025","journal-title":"Rehabil. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuro.2018.02.014","article-title":"Brain derived neurotrophic factor (BDNF), its tyrosine kinase receptor B (TrkB) and nicotine","volume":"65","author":"Machaalani","year":"2018","journal-title":"Neurotoxicology"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Girard, V., Jollivet, F., Knittelfelder, O., Celle, M., Arsac, J.N., Chatelain, G., Van den Brink, D.M., Baron, T., Shevchenko, A., and K\u00fchnlein, R.P. (2021). Abnormal accumulation of lipid droplets in neurons induces the conversion of alpha-Synuclein to proteolytic resistant forms in a Drosophila model of Parkinson\u2019s disease. PLoS Genet., 17.","DOI":"10.1371\/journal.pgen.1009921"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1016\/j.apsb.2021.02.016","article-title":"Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson\u2019s disease","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.molmed.2022.02.003","article-title":"Ferroptosis in Parkinson\u2019s disease: Glia-neuron crosstalk","volume":"28","author":"Wang","year":"2022","journal-title":"Trends Mol. Med."},{"key":"ref_42","unstructured":"Lu, M.X. (2023). Manganese Overexposure Induces Parkinson-like Symptoms and Its Association with Lipid Metabolic Disturbance in the Midbrain of Mouse. [Ph.D. Thesis, Guangxi University]."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Minato, T., Maeda, T., Fujisawa, Y., Tsuji, H., Nomoto, K., Ohno, K., and Hirayama, M. (2017). Progression of Parkinson\u2019s disease is associated with gut dysbiosis: Two-year follow-up study. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0187307"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41531-020-0112-6","article-title":"Characterizing dysbiosis of gut microbiome in PD: Evidence for overabundance of opportunistic pathogens","volume":"6","author":"Wallen","year":"2020","journal-title":"npj Park. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"117905","DOI":"10.1016\/j.biopha.2025.117905","article-title":"Microbial signatures and therapeutic strategies in neurodegenerative diseases","volume":"184","author":"Rob","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s40168-021-01107-9","article-title":"Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis","volume":"9","author":"Zhao","year":"2021","journal-title":"Microbiome"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Wang, Q., Wei, L., Chen, G., and Chen, Q. (2025). Ginsenoside Rg1 in Parkinson\u2019s disease: From basic research to clinical applications. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1490480"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11481-014-9569-6","article-title":"Potential neuroprotective activity of Ginseng in Parkinson\u2019s disease: A review","volume":"10","year":"2015","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.taap.2009.09.009","article-title":"Ginsenoside Rb1 protects against 6-hydroxydopamine-induced oxidative stress by increasing heme oxygenase-1 expression through an estrogen receptor-related PI3K\/Akt\/Nrf2-dependent pathway in human dopaminergic cells","volume":"242","author":"Hwang","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3892\/mmr.2022.12731","article-title":"Neuroprotective effect of Ginsenoside Re against neurotoxin-induced Parkinson\u2019s disease models via induction of Nrf2","volume":"25","author":"Qiao","year":"2022","journal-title":"Mol. Med. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"813","DOI":"10.31083\/j.jin2004084","article-title":"Ginsenoside Rb1 attenuates lipopolysaccharide-induced neural damage in the brain of mice via regulating the dysfunction of microglia and astrocytes","volume":"20","author":"Zhang","year":"2021","journal-title":"J. Integr. Neurosci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.toxlet.2015.12.005","article-title":"Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting \u03b1-synuclein abnormalities in the substantia nigra","volume":"243","author":"Heng","year":"2016","journal-title":"Toxicol. Lett."},{"key":"ref_53","first-page":"829","article-title":"Protective effect of ginsenoside Rg1 against MPTP-induced apoptosis in mouse substantia nigra neurons","volume":"23","author":"Chen","year":"2002","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuint.2008.10.003","article-title":"Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins","volume":"54","author":"Wang","year":"2009","journal-title":"Neurochem. Int."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nbd.2014.11.007","article-title":"Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils","volume":"74","author":"Ardah","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"ref_56","unstructured":"Li, D.W. (2021). Experimental Study of the Neuroprotective Effect of Ginsenoside Rb1 on Dopaminergic Neurons by Inhibiting Microglial Inflammation. [Ph.D. Thesis, Shandong University]."},{"key":"ref_57","first-page":"2191","article-title":"Ginsenoside Rb1 antagonizes LPS-induced nigrostriatal dopamine neuron damage via RIP1\/RIP3\/MLKL-mediated necroptosis pathway","volume":"33","author":"Jiang","year":"2024","journal-title":"Mod. J. Integr. Tradit. Chin. West. Med."},{"key":"ref_58","first-page":"7","article-title":"The mechanism of ginsenoside Rb1 in the treatment of Parkinson\u2019s disease based on network pharmacology","volume":"40","author":"Zhu","year":"2024","journal-title":"J. Baotou Med. Coll."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.neuropharm.2015.10.024","article-title":"Neuroprotective effects of ginsenoside Rg1 through the Wnt\/\u03b2-catenin signaling pathway in both in vivo and in vitro models of Parkinson\u2019s disease","volume":"101","author":"Zhou","year":"2016","journal-title":"Neuropharmacology"},{"key":"ref_60","first-page":"25","article-title":"The Mechanism of Action of Ginsenoside Rg3 for the Relief from Oxidative Stress Injury in the Nervous System of Mice with Parkinson\u2032s Disease","volume":"37","author":"Yang","year":"2024","journal-title":"West. J. Tradit. Chin. Med."},{"key":"ref_61","unstructured":"Han, Y.J. (2021). Protective Effect of Ginsenoside Rg3 on the Neurological Function in Rotenone-Induced Parkinson\u2019s Disease Mice. [Master\u2019s Thesis, Yantai University]."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41401-020-0358-x","article-title":"Rg1 improves LPS-induced Parkinsonian symptoms in mice via inhibition of NF-\u03baB signaling and modulation of M1\/M2 polarization","volume":"41","author":"Liu","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_63","first-page":"432","article-title":"Influence of Ginsenoside Rg1 on p-c-Jun and COX-2 expression in substantia nigra of the MPTP mouse model of subacute Parkinson\u2019s disease","volume":"25","author":"Wang","year":"2009","journal-title":"Chin. J. Neuroanat."},{"key":"ref_64","first-page":"1189","article-title":"Plant-derived neuroprotective agents in Parkinson\u2019s disease","volume":"7","author":"Fu","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.neuropharm.2009.09.002","article-title":"Rg1 protects the MPP+-treated MES23.5 cells via attenuating DMT1 up-regulation and cellular iron uptake","volume":"58","author":"Xu","year":"2010","journal-title":"Neuropharmacology"},{"key":"ref_66","unstructured":"Xu, H.M. (2008). The Role of Over-Expressed DMT1 in Iron Accumulation in MES23.5 Cells and the Mechanism of the Protective Effect of Ginsenoside Rg1. [Ph.D. Thesis, Qingdao University]."},{"key":"ref_67","first-page":"10","article-title":"The role of ginsenoside Rg1 in antagonism of MPTP-induced iron accumulation in substantia nigra of mice","volume":"42","author":"Yang","year":"2011","journal-title":"J. Shanxi Med. Univ."},{"key":"ref_68","first-page":"3548","article-title":"Protective mechanism of ginsenoside Re on rotenone-induced SH-SY5Y cell model of Parkinson\u2019s disease","volume":"54","author":"Zhao","year":"2023","journal-title":"Chin. Tradit. Herbal. Drugs"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Chalorak, P., Sanguanphun, T., Limboonreung, T., and Meemon, K. (2021). Neurorescue Effects of Frondoside A and Ginsenoside Rg3 in C. elegans Model of Parkinson\u2019s Disease. Molecules, 26.","DOI":"10.3390\/molecules26164843"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"107409","DOI":"10.1016\/j.micpath.2025.107409","article-title":"Protective effect of ginsenoside CK against MPTP-induced Parkinson\u2019 s disease mouse model by suppressing oxidative stress and inflammation, and modulating the gut microbiota","volume":"202","author":"Yang","year":"2025","journal-title":"Microb. Pathog."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"14395","DOI":"10.3390\/ijms160714395","article-title":"Ginsenoside Rd Protects SH-SY5Y Cells against 1-Methyl-4-phenylpyridinium Induced Injury","volume":"16","author":"Liu","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_72","first-page":"52","article-title":"Ginsenoside Rd and ginsenoside Re offer neuroprotection in a novel model of Parkinson\u2019s disease","volume":"5","author":"Zhang","year":"2016","journal-title":"Am. J. Neurodegener. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.intimp.2015.10.032","article-title":"Immunomodulatory and neuroprotective effects of ginsenoside Rg1 in the MPTP(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)\u2014induced mouse model of Parkinson\u2019s disease","volume":"29","author":"Zhou","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"ref_74","unstructured":"Li, Y.H. (2024). Exploring the Role and Mechanism of Rg1 in Ameliorating MPTP-Induced Parkinson\u2019s Disease-like Changes Based on Endoplasmic Reticulum Homeostasis. [Master\u2019s Thesis, Qingdao University]."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/j.1471-4159.2009.06051.x","article-title":"Ginsenoside Rg1 protects against 6-OHDA-induced neurotoxicity in neuroblastoma SK-N-SH cells via IGF-I receptor and estrogen receptor pathways","volume":"109","author":"Gao","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_76","unstructured":"Li, D. (2020). Neuroprotective and Therapeutic Effects of Ginsenoside Rg1 on Parkinson\u2019s Disease Rats and Its Mechanism. [Master\u2019s Thesis, North China University of Science and Technology]."},{"key":"ref_77","unstructured":"Qiao, J.H. (2024). Study on the Improvement Mechanism of Ginsenosides on Aging and Parkinson\u2019s Disease. [Ph.D. Thesis, Changchun University of Chinese Medicine]."},{"key":"ref_78","unstructured":"Zhao, G.J. (2024). Study on Improvement and Metabolomics of Ginsenoside Re in Mouse Model of Parkinson\u2019s. [Master\u2019s Thesis, Changchun University of Chinese Medicine]."},{"key":"ref_79","first-page":"1927","article-title":"Neuroprotective effect of ginsenoside Re on drosophila model of Parkinson\u2032s disease","volume":"48","author":"Xu","year":"2023","journal-title":"China J. Chin. Mater. Medica"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1749-8546-6-19","article-title":"Neuroprotective effects of ginsenosides Rh1 and Rg2 on neuronal cells","volume":"6","author":"Li","year":"2011","journal-title":"Chin. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.fct.2017.08.013","article-title":"Ginsenosides Rd and Re co-treatments improve rotenone-induced oxidative stress and mitochondrial impairment in SH-SY5Y neuroblastoma cells","volume":"109","author":"Lozan","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"ref_82","first-page":"19","article-title":"Explore the mechanism of ginsenoside Re on ferroptosis in myocardial fibrosis of heart failure rats based on Nrf2\/xCT\/GPX4 pathway","volume":"22","author":"Liu","year":"2025","journal-title":"China Med. Herald."},{"key":"ref_83","first-page":"1905","article-title":"Ginsenoside Rg1 inhibits neuronal ferroptosis caused by ischemic stroke through activating of Nrf2\/xCT\/GPX4 axis","volume":"39","author":"Hu","year":"2023","journal-title":"Chin. Pharmacol. Bull."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.2147\/IJN.S139602","article-title":"Ginsenoside Rg1 nanoparticle penetrating the blood-brain barrier to improve the cerebral function of diabetic rats complicated with cerebral infarction","volume":"12","author":"Shen","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jgr.2017.03.011","article-title":"Beneficial effects of Panax ginseng for the treatment and prevention of neurodegenerative diseases: Past findings and future directions","volume":"42","author":"Kim","year":"2018","journal-title":"J. Ginseng Res."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Xu, N., Xing, S., Li, J., Pang, B., Liu, M., Fan, M., and Zhao, Y. (2024). Water extract of ginseng alleviates parkinsonism in MPTP-induced Parkinson\u2019s disease mice. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0296424"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jgr.2024.02.003","article-title":"Metabolism and drug interactions of Korean ginseng based on the pharmacokinetic properties of ginsenosides: Current status and future perspectives","volume":"48","author":"Park","year":"2024","journal-title":"J. Ginseng Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4544\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:34:12Z","timestamp":1779338052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":87,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["ijms27104544"],"URL":"https:\/\/doi.org\/10.3390\/ijms27104544","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]}}}